Transthyretin amyloid cardiomyopathy, commonly known as ATTR CM, is a serious and often underdiagnosed heart condition. It occurs when a protein called transthyretin misfolds and builds up as amyloid deposits in the heart muscle. Over time, this buildup stiffens the heart walls, making it harder for the heart to pump blood effectively. Understanding the signs of ATTR CM is critically important, as early recognition can make a meaningful difference in a person's outcome.
What Is ATTR CM?
ATTR CM is a form of cardiac amyloidosis. The transthyretin protein is normally produced by the liver and helps transport thyroid hormones and vitamin A through the bloodstream. In people with ATTR CM, this protein becomes unstable, misfolds, and clumps together into fibrous deposits called amyloid fibrils.
These fibrils infiltrate the heart muscle, causing it to become thick and stiff. This progressive stiffening impairs the heart's ability to fill with blood between beats, a condition known as restrictive cardiomyopathy. The heart works harder and harder to do its job, eventually struggling to meet the body's demands.
The Two Types of ATTR CM
ATTR CM comes in two main forms. The first is hereditary ATTR CM (hATTR), caused by an inherited genetic mutation that makes the transthyretin protein particularly unstable. The second is wild-type ATTR CM (wtATTR), which occurs without a genetic mutation and is considered an age-related condition. Wild-type ATTR CM is far more common than previously thought and primarily affects older adults, especially men over the age of 60.
Why ATTR CM Is Often Missed
One of the greatest challenges with ATTR CM is that its symptoms closely resemble those of other, more commonly recognized heart conditions. Many patients are initially diagnosed with standard heart failure or hypertensive heart disease before ATTR CM is considered. This diagnostic delay can last years.
Increased awareness among both physicians and the general public is essential. If you or a loved one has persistent heart-related symptoms that do not fully respond to conventional treatment, it may be worth asking a doctor whether ATTR CM has been ruled out.
Common Signs and Symptoms of ATTR CM
The signs of ATTR CM can be subtle at first and tend to worsen gradually. Because the heart muscle becomes increasingly stiff, most symptoms relate to the heart's reduced ability to fill and pump blood properly. Recognizing these signs early is vital.
Shortness of Breath
Breathlessness is one of the most frequently reported symptoms. People with ATTR CM often notice they become winded during activities that previously caused no difficulty, such as climbing stairs, walking short distances, or even dressing themselves. As the disease progresses, shortness of breath may occur even at rest or while lying flat.
Fatigue and Weakness
A persistent, unexplained sense of tiredness is common. Because the heart is not pumping blood as efficiently as it should, the muscles and organs throughout the body receive less oxygen and nutrients. This can lead to a general feeling of weakness and low energy that does not improve with rest.
Swelling in the Legs, Ankles, and Feet
Fluid retention, known as edema, frequently develops as the heart struggles to manage blood flow. Swelling typically begins in the ankles and feet and can extend up the legs. The swelling may be more noticeable at the end of the day or after prolonged sitting or standing.
Irregular Heartbeat
Amyloid deposits in the heart can interfere with its electrical system. This can cause arrhythmias, or abnormal heart rhythms. Some people experience palpitations, a fluttering or racing sensation in the chest. Others may notice their heart beating too slowly or in an erratic pattern.
Dizziness and Lightheadedness
People with ATTR CM may experience episodes of dizziness, particularly when standing up quickly. This can be related to the heart's reduced output or to changes in blood pressure. In some cases, these episodes may lead to fainting, known medically as syncope.
Exercise Intolerance
A noticeable and progressive decline in the ability to exercise is a hallmark sign. Activities that were once routine may become exhausting or impossible. This reduced exercise capacity is a reflection of the heart's diminishing functional reserve.
Signs Beyond the Heart
ATTR CM is a systemic disease, meaning the transthyretin protein can deposit in tissues throughout the body, not just the heart. Many patients experience symptoms outside the cardiovascular system, and these can actually serve as important diagnostic clues.
Carpal Tunnel Syndrome
One of the most telling early clues is bilateral carpal tunnel syndrome, meaning it affects both wrists. When carpal tunnel syndrome affects both hands and requires surgical treatment, particularly in men over 60, doctors are increasingly trained to consider whether ATTR CM may be the underlying cause. Amyloid deposits in the wrist's carpal tunnel compress the median nerve, causing numbness, tingling, and pain in the hands and fingers.
Spinal Stenosis
Amyloid deposits in the spine can narrow the spinal canal, putting pressure on the spinal cord or nerve roots. This can cause back pain, numbness, and weakness in the legs. Like carpal tunnel syndrome, spinal stenosis that requires surgery in older adults may sometimes point to underlying amyloid disease.
Peripheral Neuropathy
Particularly in the hereditary form of ATTR CM, amyloid deposits can damage peripheral nerves throughout the body. This may manifest as numbness, tingling, burning, or pain in the hands and feet. Some people also experience difficulty with balance and coordination.
Autonomic Neuropathy
The autonomic nervous system controls involuntary functions like blood pressure, digestion, and bladder control. When amyloid affects these nerves, patients may experience symptoms such as dizziness upon standing, digestive problems including constipation or diarrhea, unexplained weight loss, and urinary difficulties.
Gastrointestinal Symptoms
Some people with ATTR CM report persistent digestive issues including nausea, bloating, alternating bouts of constipation and diarrhea, and changes in appetite. These symptoms result from amyloid infiltration of the nerves and tissues that control digestive function.
Signs Detected During Medical Evaluation
While many signs of ATTR CM are felt by the patient, others are detected only through clinical examination and diagnostic testing. Knowing which findings your doctor may look for can help you understand your evaluation more clearly.
Thickened Heart Walls
One of the most consistent findings in ATTR CM is an abnormal thickening of the heart muscle walls, particularly the left ventricular wall. This thickening is often detected during an echocardiogram, which is an ultrasound of the heart. Unlike the thickening seen in high blood pressure, the pattern in ATTR CM tends to be more symmetrical and is associated with a characteristic appearance sometimes described as a sparkling or granular texture within the heart muscle.
Low Voltage on Electrocardiogram
An electrocardiogram, or ECG, measures the electrical signals produced by the heart. In many ATTR CM patients, the ECG paradoxically shows low-voltage signals despite the presence of thickened heart muscle. This mismatch between electrical signals and wall thickness is an important diagnostic clue that can prompt further investigation.
Elevated Heart Failure Markers
Blood tests can reveal elevated levels of certain proteins that the heart releases when it is under stress. These biomarkers help doctors assess the degree of heart muscle involvement and can be used to monitor disease progression over time.
Enlarged Heart and Fluid Around the Lungs
A chest X-ray may reveal an enlarged heart or fluid accumulation in the lungs and surrounding spaces. These findings indicate that the heart is not managing fluid balance effectively, a consequence of its impaired pumping function.
Imaging Approaches in Diagnosis
When ATTR CM is suspected, doctors use several specialized imaging tools to investigate further and confirm the diagnosis.
Echocardiography
Echocardiography remains the most accessible initial imaging test. It provides detailed images of heart structure and function. In ATTR CM, it typically reveals thickened walls, reduced pumping efficiency in some stages, and sometimes an appearance of the heart muscle that experienced cardiologists recognize as characteristic of amyloid infiltration.
Advanced Heart Imaging Scans
Cardiac magnetic resonance imaging, often called cardiac MRI, is an advanced imaging technique that provides highly detailed pictures of the heart's structure and tissue characteristics. A specific pattern seen on cardiac MRI known as late gadolinium enhancement can suggest amyloid deposits in the heart muscle, though the agent used for this scan is not specific to amyloid alone.
A specialized bone scan using a radioactive tracer is now widely recognized as a highly effective non-invasive way to confirm ATTR CM. When this type of imaging shows significant uptake of the tracer within the heart muscle, it is considered strongly supportive of the diagnosis, often allowing doctors to avoid a biopsy in many patients.
Tissue Biopsy
In some cases, a small tissue sample may be taken and examined under a microscope to look for amyloid deposits. The biopsy may be taken from the heart itself or from an easier-to-access tissue such as abdominal fat or a salivary gland. When amyloid is found, additional testing is done to determine whether it is the transthyretin type, confirming the ATTR CM diagnosis.
Genetic Testing in ATTR CM
When ATTR CM is diagnosed or strongly suspected, genetic testing is an important step. A simple blood test can reveal whether a person carries a mutation in the gene responsible for producing transthyretin. If a mutation is found, family members may be advised to undergo genetic counseling and testing as well, since the condition can be inherited.
Many different mutations have been identified, and they vary in prevalence across different ethnic backgrounds. Certain mutations are significantly more common in people of West African ancestry, making awareness particularly important in those communities.
Who Is Most at Risk?
Understanding risk factors for ATTR CM helps identify people who should be monitored more closely or screened earlier.
Age
Wild-type ATTR CM is primarily a disease of older age. The vast majority of cases occur in people over 60, with the average age at diagnosis being in the 70s or 80s. As the global population ages, the number of people affected by this condition is expected to increase.
Sex
Men are significantly more likely to develop wild-type ATTR CM than women. The reasons for this disparity are not fully understood, though hormonal factors may play a protective role in women.
Family History
A family history of ATTR CM, unexplained heart failure, peripheral neuropathy, or related conditions should prompt a conversation with a doctor about whether genetic screening is appropriate.
Ethnicity
Individuals of West African descent carry a higher prevalence of a specific transthyretin gene variant that substantially increases the risk of hereditary ATTR CM. Awareness of this disparity is essential for ensuring equitable diagnosis and care across all populations.
The Importance of Early Recognition
ATTR CM is a progressive disease, meaning it worsens over time without appropriate management. However, the progression can be slowed and quality of life improved when the condition is recognized early and managed by a specialized medical team. Treatment plans typically involve a cardiologist experienced in amyloidosis, and may include medications your doctor prescribes to manage symptoms and address the underlying disease process.
Beyond medication, doctors may recommend lifestyle adjustments, careful monitoring of fluid balance, and in some cases, evaluation for more advanced heart interventions. For patients with severe electrical disturbances in the heart, implanted devices to regulate heart rhythm may be considered.
Living With ATTR CM: What Patients Should Know
Receiving a diagnosis of ATTR CM can be overwhelming, but many patients live meaningful, active lives for years after diagnosis. Working closely with a knowledgeable medical team, attending regular follow-up appointments, and reporting any new or worsening symptoms promptly are all essential parts of managing the condition.
Patient support organizations and advocacy groups can be valuable resources, offering information, community, and guidance for navigating the healthcare system. Connecting with others who share the diagnosis can also provide emotional support and practical insights.
Monitoring for Disease Progression
Regular medical assessments help doctors track how the disease is evolving. These may include periodic echocardiograms, blood tests to measure heart stress markers, and assessments of physical function. Changes in these measures guide decisions about adjusting the management plan.
Communicating With Your Healthcare Team
Patients are encouraged to ask questions and advocate for themselves during medical appointments. If you are experiencing new symptoms or feel that something has changed, sharing that information promptly with your doctor is important. A well-informed patient who actively participates in their care tends to have better outcomes.
Raising Awareness About ATTR CM
ATTR CM has historically been dramatically underdiagnosed. Studies suggest that many people living with unexplained heart failure, particularly older men with certain characteristic findings, may actually have ATTR CM without knowing it. Raising awareness among the general public and within the medical community is an ongoing effort.
If you are an older adult experiencing unexplained shortness of breath, fatigue, leg swelling, or other heart-related symptoms, especially alongside a history of carpal tunnel syndrome or peripheral neuropathy, it is worth raising the possibility of ATTR CM with your doctor. Being an informed advocate for your own health could lead to a diagnosis and care plan that significantly improves your quality of life.
ATTR CM is no longer the untreatable condition it once was. With growing awareness, better diagnostic tools, and an expanding range of treatment options, the outlook for patients has improved considerably. Understanding the signs is the first and most important step.
